← Every applicant
Appco FDA Approvals
14 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| FLUVOXAMINE MALEATENew drugApr 30, 2026CAPSULE, EXTENDED RELEASE, ORAL |
| ACAMPROSATE CALCIUMNew drugMar 16, 2026TABLET, DELAYED RELEASE, ORAL |
| HYDROCORTISONENew drugFeb 25, 2026TABLET, ORAL |
| SERTRALINE HYDROCHLORIDENew drugJan 20, 2026CAPSULE, ORAL |
| PRUCALOPRIDE SUCCINATENew drugJun 24, 2025TABLET, ORAL |
| TRANEXAMIC ACIDNew drugJun 11, 2025TABLET, ORAL |
| CLOMIPHENE CITRATENew drugNov 8, 2024TABLET, ORAL |
| BUMETANIDENew drugSep 18, 2024TABLET, ORAL |
| VALGANCICLOVIR HYDROCHLORIDENew drugApr 11, 2023FOR SOLUTION, ORAL |
| PRAZOSIN HYDROCHLORIDENew drugOct 21, 2022CAPSULE, ORAL |
| PERPHENAZINENew drugMay 18, 2022TABLET, ORAL |
| DOFETILIDENew drugApr 14, 2022CAPSULE, ORAL |
| CARBAMAZEPINENew drugAug 16, 2021TABLET, ORAL |
| DOXEPIN HYDROCHLORIDENew drugApr 1, 2021CAPSULE, ORAL |